Edition:
United States

Jeil Pharma Holdings Inc (002620.KS)

002620.KS on Korea Stock Exchange

38,850.00KRW
18 Aug 2017
Change (% chg)

₩-950.00 (-2.39%)
Prev Close
₩39,800.00
Open
₩39,450.00
Day's High
₩40,100.00
Day's Low
₩38,300.00
Volume
54,699
Avg. Vol
77,580
52-wk High
₩369,071.00
52-wk Low
₩38,050.00

002620.KS

Chart for 002620.KS

About

JEIL PHARMA HOLDINGS INC., formerly Jeil Pharmaceutical Co.,Ltd is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company provides antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, anticancer drugs, tristimania drugs, gastritis drugs,... (more)
No analyst recommendations are available for 002620.KS.

Overall

Beta: 0.52
Market Cap(Mil.): ₩168,823.00
Shares Outstanding(Mil.): 4.35
Dividend: 239.21
Yield (%): 0.62

Financials

  002620.KS Industry Sector
P/E (TTM): 20.89 31.45 32.56
EPS (TTM): 1,860.11 -- --
ROI: 2.43 15.33 14.89
ROE: 2.82 16.35 16.13

BRIEF-Jeil Pharmaceutical changes CEO to Han Sang Chul

* Says it changed CEO of the co to Han Sang Chul from Sung Seok Je

Jun 02 2017

Earnings vs. Estimates

No consensus analysis data available.